# Rocky Mountain Tissue Bank – FDA Inspection, Oct 24, 2016

Source: https://www.keypedia.com/records/fda_inspections/rocky-mountain-tissue-bank/60ff9dbd-00ec-43e4-b0f4-e26db833c2ca
Source feed: FDA_Inspections

> FDA inspection 997992 of Rocky Mountain Tissue Bank, October 24, 2016. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 997992
- Company Name: Rocky Mountain Tissue Bank
- Inspection Date: 2016-10-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1233237 - 2024-03-04
- FDA Inspection 1071051 - 2018-10-17
- FDA Inspection 900994 - 2014-10-22
- [FDA Inspection 823145 - 2013-02-22](https://www.keypedia.com/records/fda_inspections/rocky-mountain-tissue-bank/5fd402d9-4ea8-4b72-8d98-97537920f14a)
- FDA Inspection 709950 - 2011-02-15

## Related Officers

- [Company Rep](https://www.keypedia.com/people/marc-a-jackson/3bb8df6e-ab3a-4106-9a4b-aaaa307bc051)

Company: https://www.keypedia.com/companies/rocky-mountain-tissue-bank/ec319162-df1d-4800-a6e4-a5dff5f3c202

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d